Foundation Medicine (FMI) Misses Q2 EPS by 13c

Foundation Medicine (NASDAQ: FMI) reported Q2 EPS of ($1.24), $0.13 worse than the analyst estimate of ($1.11). Revenue for the quarter came in at $35 million versus the consensus estimate of $34.94 million.

GUIDANCE:

Foundation Medicine sees FY2017 revenue of $135-145 million, versus the consensus of $139.2 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
• Prenetics Global (PRE) Tops Q2 EPS by 18c